Related references
Note: Only part of the references are listed.Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS
Shruti Chaturvedi et al.
BLOOD (2020)
Cryptic conspirators: a conversation about thrombocytopenia and antiphospholipid syndrome
Andrew P. Vreede et al.
CURRENT OPINION IN RHEUMATOLOGY (2019)
The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review
Ricard Cervera et al.
JOURNAL OF AUTOIMMUNITY (2018)
Diagnosis and Management of the Antiphospholipid Syndrome
David Garcia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study
R. Hisada et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Eculizumab cessation in atypical hemolytic uremic syndrome
Samuel A. Merrill et al.
BLOOD (2017)
Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry
Ignasi Rodriguez-Pinto et al.
AUTOIMMUNITY REVIEWS (2016)
The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome
Doruk Erkan et al.
TURKISH JOURNAL OF HEMATOLOGY (2016)
Signal for Thrombosis with Eltrombopag and Romiplostim: A Disproportionality Analysis of Spontaneous Reports Within VigiBaseA®
Thi-Thanh Loan Nguyen et al.
DRUG SAFETY (2015)
Eculizumab Prevents Recurrent Antiphospholipid Antibody Syndrome and Enables Successful Renal Transplantation
B. E. Lonze et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Monitoring anticoagulation in patients with an unreliable prothrombin time/international normalized ratio: factor II versus chromogenic factor X testing
Lisa M. Baumann Kreuziger et al.
BLOOD COAGULATION & FIBRINOLYSIS (2014)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)